OnKure Therapeutics, Inc.·4

Jul 2, 4:26 PM ET

Manke Isaac 4

4 · OnKure Therapeutics, Inc. · Filed Jul 2, 2025

Insider Transaction Report

Form 4
Period: 2025-06-30
Manke Isaac
Director
Transactions
  • Award

    Class A Common Stock

    2025-06-30+6,3119,780 total
Footnotes (1)
  • [F1]These securities are fully vested restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of Class A Common Stock. The RSUs were granted to the Reporting Person in lieu of a quarterly cash retainer, at the election of the Reporting Person, under the Issuer's Outside Director Compensation Policy.

Documents

1 file
  • 4
    form4-07022025_080710.xmlPrimary